The climax of a standoff with the pharmaceutical industry over high prices
The actual problem with vaccines is cost and access.
Of course, the doctors do see donations as valuable—simply not worth the costs in this context, which transcends seemingly straightforward philanthropy and medical science.
cost is the fundamental issue to Jason Cone, the executive director of Doctors Without Borders in the United States. He explained that donations from pharmaceutical companies are ineffective against a problem of this scale. While the donation would benefit people under the care of Doctors Without Borders immediately, accepting it could mean problems for others, and problems longer-term. Donations, he writes, are “often used as a way to make others ‘pay up.’ By giving the pneumonia vaccine away for free, pharmaceutical corporations can use this as justification for why prices remain high for others, including other humanitarian organizations and developing countries that also can’t afford the vaccine.”